|
|
||||||||
The FASEB Journal, Vol 8, 1012-1018, Copyright © 1994 by The Federation of American Societies for Experimental Biology
REVIEWS |
D Yuan, CY Koh and JA Wilder
Department of Pathology, University of Texas Southwestern Medical Center, Dallas 75235.
The ability of natural killer (NK) cells to secrete lymphokines confers upon them the potential to regulate cell types via mechanisms other than direct cytotoxicity. During the past few years increasing evidence has been accumulating to show that NK and B cells can interact productively. First, NK cells cocultured with B cells can induce them to initiate polyclonal Ig secretion. This help is mediated by a soluble factor (or factors) that appears to be different from any known cytokine. Second, preactivated B lymphocytes can induce NK cells to produce greater amounts of IFN-gamma via an interaction that requires direct cell contact. Third, in contrast to previous suggestions, NK cells do not have the ability to kill primary B lymphocytes regardless of their stage of differentiation. Evaluation of the in vivo relevance of these interactions revealed that activated NK cells can increase the IgG2a response to a specific protein antigen. Without activation, NK cells neither enhance nor inhibit B cell responses to antigens. The deviation of the isotype distribution may allow increased NK cell specificity for certain pathogens by enhancing antibody-dependent cytotoxicity.
This article has been cited by other articles:
![]() |
A.-H. Hovav, L. Davidovitch, G. Nussbaum, J. Mullerad, Y. Fishman, and H. Bercovier Mitogenicity of the Recombinant Mycobacterial 27-Kilodalton Lipoprotein Is Not Connected to Its Antiprotective Effect Infect. Immun., June 1, 2004; 72(6): 3383 - 3390. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Orengo, E. Di Carlo, A. Comes, M. Fabbi, T. Piazza, M. Cilli, P. Musiani, and S. Ferrini Tumor Cells Engineered with IL-12 and IL-15 Genes Induce Protective Antibody Responses in Nude Mice J. Immunol., July 15, 2003; 171(2): 569 - 575. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Loza, L. Zamai, L. Azzoni, E. Rosati, and B. Perussia Expression of type 1 (interferon gamma) and type 2 (interleukin-13, interleukin-5) cytokines at distinct stages of natural killer cell differentiation from progenitor cells Blood, February 15, 2002; 99(4): 1273 - 1281. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. R. Blanca, E. W. Bere, H. A. Young, and J. R. Ortaldo Human B Cell Activation by Autologous NK Cells Is Regulated by CD40-CD40 Ligand Interaction: Role of Memory B Cells and CD5+ B Cells J. Immunol., December 1, 2001; 167(11): 6132 - 6139. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Gao, T. Dang, and D. Yuan IFN-{gamma}-Dependent and -Independent Initiation of Switch Recombination by NK Cells J. Immunol., August 15, 2001; 167(4): 2011 - 2018. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Harandi, B. Svennerholm, J. Holmgren, and K. Eriksson Differential roles of B cells and IFN-{{gamma}}-secreting CD4+ T cells in innate and adaptive immune control of genital herpes simplex virus type 2 infection in mice J. Gen. Virol., April 1, 2001; 82(4): 845 - 853. [Abstract] [Full Text] |
||||
![]() |
M. K. Demetrikopoulos, R. H. Goldfarb, Z.-b. Zhang, and J. M. Weiss Blood Level of B and CD4+ Lymphocytes Measured before Induction of an Experimental Tumor in Rats Predicts Tumor Progression and Survival Cancer Epidemiol. Biomarkers Prev., June 1, 2000; 9(6): 609 - 617. [Abstract] [Full Text] |
||||
![]() |
K. L. Elkins, C. M. Bosio, and T. R. Rhinehart-Jones Importance of B cells, but Not Specific Antibodies, in Primary and Secondary Protective Immunity to the Intracellular Bacterium Francisella tularensis Live Vaccine Strain Infect. Immun., November 1, 1999; 67(11): 6002 - 6007. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Quan, Z.-b. Zhang, M. K. Demetrikopoulos, R. P. Kitson, W. H. Chambers, R. H. Goldfarb, and J. M. Weiss Evidence for Involvement of B Lymphocytes in the Surveillance of Lung Metastasis in the Rat Cancer Res., March 1, 1999; 59(5): 1080 - 1089. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hoek, J. Schoemaker, and H. A. Drexhage Premature Ovarian Failure and Ovarian Autoimmunity Endocr. Rev., February 1, 1997; 18(1): 107 - 134. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |